# Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity

> **NCT02241109** · NA · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 200 (actual)

## Conditions studied

- Aortic Valve Sclerosis
- Aortic Valve Stenosis
- Stenosis Progression
- Valvular Heart Disease

## Interventions

- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT02241109
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-30
- **Primary completion:** 2016-01-31
- **Final completion:** 2017-02-28
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02241109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02241109, "Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02241109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*